WELCOME TO THE SSBTR WEBSITE!

Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Childrens Hospital, Steele Childrens Research Center in Tucson, and Translational Genomics Research Institute (TGen). With your help we can make a difference. The intent of our website is to further our objectives of disseminating information about this disease process, stimulating more widespread involvement within our community through donating, volunteering and participating in one or more of our events, and publicizing and promoting this exceptional student-run organization.

"Be the change you wish to see in the world..." Gandhi

Thanks for visiting. Your support is greatly appreciated.

SSBTR on the News

Videos


Philanthropic "Quotes"

  • “Difficult things we do quickly. The impossible takes a little longer.”

  • “Generosity is the flower of justice.”

  • “Philanthropy is almost the only virtue which is sufficiently appreciated by mankind.”


RECENT BRAIN TUMOR ARTICLES

BLANK LINE

Brain Tumor News

  • First use of graphene to detect cancer cells

  • With support from the Clinical and Translational Science Awards (CTSAs) at Duke and Carolina, Baldwin and Lo have teamed up to better understand the heterogeneity of brain cancer, using a new approach they’ve pioneered for growing and characterizing miniature human brain tumors in the lab. Ultimately, they hope to find new treatments or combinations of treatments to help more glioblastoma patients beat the odds.

  • A new class of therapies called SMAC mimetics could work in conjunction with immune checkpoint inhibitors to treat brain cancer patients, according to a study. SMAC mimetics block the activity of proteins that prevent cell death while sensitizing tumors to allow immune cells to attack them.

  • Researchers at the Yale School of Medicine’s Department of Therapeutic Radiology have identified a genetic defect in brain tumor cells that makes them sensitive to a class of drugs known as PARP inhibitors.

  • SRS microscopy has shown to quickly detect brain-tumor even in fresh and raw human tissue sample. The technique may serve as an effective alternative to traditional histologic procedures

blank line

SSBTR in the News

  • A new class of therapies called SMAC mimetics could work in conjunction with immune checkpoint inhibitors to treat brain cancer patients, according to a study. SMAC mimetics block the activity of proteins that prevent cell death while sensitizing tumors to allow immune cells to attack them.

  • Researchers at the Yale School of Medicine’s Department of Therapeutic Radiology have identified a genetic defect in brain tumor cells that makes them sensitive to a class of drugs known as PARP inhibitors.

© Copyright 2017